UMIN ID: UMIN000001198
Registered date:20/06/2008
Cilostazol trial
Basic Information
| Recruitment status | Complete: follow-up complete |
|---|---|
| Health condition(s) or Problem(s) studied | peripheral arterial disease |
| Date of first enrollment | 2004/10/01 |
| Target sample size | 80 |
| Countries of recruitment | Japan |
| Study type | Interventional |
| Intervention(s) | Aspirin 81-100mg/day Aspirin 81-100mg/day + cilostazol 200mg/day |
Outcome(s)
| Primary Outcome | target vessel revascularization |
|---|---|
| Secondary Outcome | major adverse cardiovascular event, restenosis rate |
Key inclusion & exclusion criteria
| Age minimum | 20years-old |
|---|---|
| Age maximum | 80years-old |
| Gender | Male and Female |
| Include criteria | |
| Exclude criteria | previous lower extremity bypass surgery, previous EVT in the femoropopliteal artery, acute onset limb ischemia, or severe lower extremity ischemic symptoms classified into Rutherford Category 4, 5 or 6, known bleeding diathesis, hepatic dysfunction, active gastrointestinal bleeding or peptic ulcer disease, intolerance to cilostazol, aspirin or ticlopidine, pregnant women and women of child-bearing potential, and major life-threatening illness. |
Related Information
| Primary Sponsor | Kokura Memorial Hospital |
|---|---|
| Secondary Sponsor | |
| Source(s) of Monetary Support | none |
| Secondary ID(s) |
Contact
| public contact | |
| Name | |
| Address | 1-1 Kifune-machi Kokurakita-ku Kitakyusyu city Fukuoka Japan Japan |
| Telephone | 093-921-2231 |
| Affiliation | Kokura Memorial Hospital cardiology |
| scientific contact | |
| Name | Hiroyoshi Yokoi |
| Address | 1-1 Kifune-machi Kokurakita-ku Kitakyusyu city Fukuoka Japan Japan |
| Telephone | 093-921-2231 |
| Affiliation | Kokura Memorial Hospital Cardiology |